Segment, Customer and Geographic Information

12 Months Ended

Dec. 31, 2023

Segment Reporting [Abstract]

Segment, Customer and Geographic Information

Note 16. Segment, Customer and Geographic Information

The Company continues to operate in only one segment, blood safety. The Company’s chief executive officer is the chief operating decision maker who evaluates performance based on the net revenues and operating loss of the blood safety segment. The Company considers the sale of all of its INTERCEPT Blood System products to be similar in nature and function, and any revenue earned from services is minimal.

The Company’s operations outside of the U.S. include a wholly-owned subsidiary headquartered in Europe. The Company’s operations in the U.S. are responsible for the R&D and global and domestic commercialization of the INTERCEPT Blood System, while operations in Europe are responsible for the commercialization efforts of the platelet and plasma systems in Europe, the Commonwealth of Independent States and the Middle East. Product revenues are attributed to each region based on the location of the customer, and in the case of non-product revenues, on the location of the collaboration partner.

The Company had the following significant customers that accounted for more than 10% of the Company’s total product revenue, during the years ended December 31, 2023, 2022 and 2021 (in percentages):

	Year Ended December 31,
	2023	2022	2021
American Red Cross	35%	35%	30%
Établissement Français du Sang	12%	12%	16%

Revenues by geographical location were based on the location of the customer during the years ended December 31, 2023, 2022 and 2021, and was as follows (in thousands):

	Year Ended December 31,
	2023		2022		2021
Product revenue:
United States	$	93,232	$	101,391	$	67,498
France		18,490		19,327		20,887
Other countries		44,645		41,330		42,474
Total product revenue		156,367		162,048		130,859
Government contract revenue:
United States		30,430		26,267		28,659
Total government contract revenue		30,430		26,267		28,659
Total revenue	$	186,797	$	188,315	$	159,518

Long-lived assets by geographical location at December 31, 2023 and December 31, 2022, were as follows (in thousands):

	December 31,
	2023		2022
United States	$	8,444	$	10,705
Europe & other		196		264
Total long-lived assets	$	8,640	$	10,969